Ferring names new chief medical officer

Pharmaceutical Company Restructures

Ferring has announced the appointment of Professor Klaus Dugi as its new executive vice-president and chief medical officer with immediate effect.

Professor Dugi is an experienced scientist and business leader who was previously employed at Boehringer Ingelheim, where he served as vice-president for global medical affairs, chief medical officer and, most recently, as managing director for the UK and Ireland.

“Ferring Pharmaceuticals has named Professor Klaus Dugi, formerly of Boehringer Ingelheim, as its new executive vice-president and chief medical officer.“

The professor of medicine also spent four years carrying out research at the US National Institutes of Health and has published more than 70 manuscripts in peer-reviewed journals such as The Lancet and Diabetes.

In his new role at Ferring, he will be responsible for its global medical affairs, quality assurance and pharmacovigilance functions, as well as taking up a place on the company's executive board.

Michel Pettigrew, president of the executive board and chief operating officer at Ferring Pharmaceuticals, said: "Making the industry more patient-centric has always been a top priority for Professor Dugi, and this is perfectly aligned with our company philosophy and commitment to solving unmet patient needs."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.

See all the latest jobs in Pharmaceutical
Return to news